IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 11 filers reported holding IBERE PHARMACEUTICALS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $179,859 | -90.7% | 18,040 | -90.8% | 0.27% | -29.4% |
| Q3 2022 | $1,934,000 | -1.5% | 195,202 | -2.6% | 0.38% | +3.3% |
| Q2 2022 | $1,964,000 | -5.0% | 200,412 | -5.0% | 0.37% | -8.9% |
| Q1 2022 | $2,067,000 | -10.8% | 210,952 | -8.8% | 0.40% | -18.5% |
| Q4 2021 | $2,317,000 | -7.5% | 231,182 | -7.7% | 0.50% | -17.7% |
| Q3 2021 | $2,504,000 | -10.1% | 250,502 | -9.6% | 0.60% | -13.6% |
| Q2 2021 | $2,786,000 | -3.7% | 277,192 | -5.5% | 0.70% | -10.8% |
| Q1 2021 | $2,893,000 | – | 293,440 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |